 | Up a level |
Fey, Martin F; O'Reilly, Seamus; Awada, Ahmad H; Crowley, John; Gelmon, Karen A (2024). Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials. Current opinion in oncology, 36(5), pp. 418-420. Wolters Kluwer Health 10.1097/CCO.0000000000001056
Chapman, Judith-Anne W; Bayani, Jane; SenGupta, Sandip; Bartlett, John M S; Piper, Tammy; Quintayo, Mary Anne; Virk, Shakeel; Goss, Paul E; Ingle, James N; Ellis, Matthew J; Sledge, George W; Budd, G Thomas; Rabaglio, Manuela; Ansari, Rafat H; Tozer, Richard; D'Souza, David P; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A; ... (2024). Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole. Journal of clinical oncology, 42(24), pp. 2887-2898. American Society of Clinical Oncology 10.1200/JCO.24.00835
Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Thompson, Alastair M; Rea, Daniel W; Stos, Paul M; Shepherd, Lois E; Stambolic, Vuk; Parulekar, Wendy R (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(35), pp. 5356-5362. 10.1200/JCO.23.00296
Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D; Mackey, John R; Abramson, Vandana G; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M; Rea, Daniel W; ... (2022). Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. JAMA : the journal of the American Medical Association, 327(20), pp. 1963-1973. American Medical Association 10.1001/jama.2022.6147
Tutt, Andrew N J; Garber, Judy E; Kaufman, Bella; Viale, Giuseppe; Fumagalli, Debora; Rastogi, Priya; Gelber, Richard D; de Azambuja, Evandro; Fielding, Anitra; Balmaña, Judith; Domchek, Susan M; Gelmon, Karen A; Hollingsworth, Simon J; Korde, Larissa A; Linderholm, Barbro; Bandos, Hanna; Senkus, Elżbieta; Suga, Jennifer M; Shao, Zhimin; Pippas, Andrew W; ... (2021). Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. The New England journal of medicine, 384(25), pp. 2394-2405. Massachusetts Medical Society 10.1056/NEJMoa2105215
Drögemöller, Britt I; Wright, Galen E B; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin J D; Amstutz, Ursula; Carleton, Bruce C (2019). CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines. Breast cancer research and treatment, 173(3), pp. 521-532. Springer 10.1007/s10549-018-5027-0
Strasser-Weippl, Kathrin; Higgins, Michaela J; Chapman, Judith-Anne; Ingle, James; Sledge, George W; Budd, George T; Ellis, Matthew; Pritchard, Kathleen; Clemons, Mark J; Badovinac-Crnjevic, Tanja; Han, Lei; Gelmon, Karen A; Rabaglio, Manuela; Elliott, Catherine; Shepherd, Lois; Goss, Paul E (2018). Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27. Journal of the National Cancer Institute JNCI, 110(9), pp. 1003-1008. Oxford University Press 10.1093/jnci/djy017
Drögemöller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin J D; Gelmon, Karen A; ... (2017). Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA oncology, 3(11), pp. 1558-1562. American Medical Association 10.1001/jamaoncol.2017.0502
Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Hwang, Soomi; Rieder, Michael J; Bhavsar, Amit P; Smith, Anne; Sanatani, Shubhayan; Gelmon, Karen A; Bernstein, Daniel; Hayden, Michael R; Carleton, Bruce C; Amstutz, Ursula (2016). Recommendations for Genetic Testing to Reduce the Incidence of Anthracycline-induced Cardiotoxicity. British journal of clinical pharmacology, 82(3), pp. 683-695. Wiley-Blackwell 10.1111/bcp.13008
